139 related articles for article (PubMed ID: 14659660)
1. Activity of combinations of ceftazidime, imipenem and pefloxacin against Staphylococcus aureus, Escherichia coli and Pseudomonas aeruginosa.
El-Sukhon SN; Faiza Boukhatem Z
Int J Antimicrob Agents; 2003 Dec; 22(6):613-7. PubMed ID: 14659660
[TBL] [Abstract][Full Text] [Related]
2. Combination therapy: a way to limit emergence of resistance?
Michéa-Hamzehpour M; Pechère JC; Marchou B; Auckenthaler R
Am J Med; 1986 Jun; 80(6B):138-42. PubMed ID: 3088999
[TBL] [Abstract][Full Text] [Related]
3. In vitro activity of azithromycin in combination with amikacin, ceftazidime, ciprofloxacin or imipenem against clinical isolates of Acinobacter baumannii.
Fernández-Cuenca F; Martínez-Martínez L; Pascual A; Perea EJ
Chemotherapy; 2003 May; 49(1-2):24-6. PubMed ID: 12714805
[TBL] [Abstract][Full Text] [Related]
4. Antibacterial Properties of Tebipenem Pivoxil Tablet, a New Oral Carbapenem Preparation against a Variety of Pathogenic Bacteria in Vitro and in Vivo.
Yao Q; Wang J; Cui T; Yang Z; Su M; Zhao P; Yan H; Zhan Y; Yang H
Molecules; 2016 Jan; 21(1):62. PubMed ID: 26751436
[TBL] [Abstract][Full Text] [Related]
5. In vitro activity of fosfomycin-gentamicin, fosfomycin-ceftazidime, fosfomycin-imipenem and ceftazidime-gentamicin combinations against ceftazidime-resistant Pseudomonas aeruginosa.
Pruekprasert P; Tunyapanit W
Southeast Asian J Trop Med Public Health; 2005 Sep; 36(5):1239-42. PubMed ID: 16438151
[TBL] [Abstract][Full Text] [Related]
6. Basis for nebulized antibiotics: droplet characterization and in vitro antimicrobial activity versus Staphylococcus aureus, Escherichia coli, and Pseudomonas aeruginosa.
Todisco T; Eslami A; Baglioni S; Sposini T; Tascini C; Sommer E; Knoch M
J Aerosol Med; 2000; 13(1):11-6. PubMed ID: 10947319
[TBL] [Abstract][Full Text] [Related]
7. Determination of synergy by two methods with eight antimicrobial combinations against tobramycin-susceptible and tobramycin-resistant strains of Pseudomonas.
Chan EL; Zabransky RJ
Diagn Microbiol Infect Dis; 1987 Feb; 6(2):157-64. PubMed ID: 3102156
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of synergistic activity of bovine lactoferricin with antibiotics in corneal infection.
Oo TZ; Cole N; Garthwaite L; Willcox MD; Zhu H
J Antimicrob Chemother; 2010 Jun; 65(6):1243-51. PubMed ID: 20375033
[TBL] [Abstract][Full Text] [Related]
9. In vivo antibacterial activity of S-3578, a new broad-spectrum cephalosporin: methicillin-resistant Staphylococcus aureus and Pseudomonas aeruginosa experimental infection models.
Tsuji M; Takema M; Miwa H; Shimada J; Kuwahara S
Antimicrob Agents Chemother; 2003 Aug; 47(8):2507-12. PubMed ID: 12878512
[TBL] [Abstract][Full Text] [Related]
10. Bactericidal effect of combinations of antibiotic and antineoplastic agents against Staphylococcus aureus and Escherichia coli.
Nyhlén A; Ljungberg B; Nilsson-Ehle I; Odenholt I
Chemotherapy; 2002 May; 48(2):71-7. PubMed ID: 12011538
[TBL] [Abstract][Full Text] [Related]
11. The post-antibiotic effect of antimicrobial combinations in a neutropenic murine thigh infection model.
Gudmundsson S; Einarsson S; Erlendsdottir H; Moffat J; Bayer W; Craig WA
J Antimicrob Chemother; 1993 May; 31 Suppl D():177-91. PubMed ID: 8335520
[TBL] [Abstract][Full Text] [Related]
12. In vitro efficacy of various antibiotic combinations against Pseudomonas aeruginosa isolates.
Nazli E; Zer Y; Eksi F
J Int Med Res; 2015 Apr; 43(2):217-25. PubMed ID: 25547417
[TBL] [Abstract][Full Text] [Related]
13. Bactericidal activity and killing rate of serum from volunteers receiving pefloxacin alone or in combination with amikacin.
Van der Auwera P; Klastersky J; Lieppe S; Husson M; Lauzon D; Lopez AP
Antimicrob Agents Chemother; 1986 Feb; 29(2):230-4. PubMed ID: 3087276
[TBL] [Abstract][Full Text] [Related]
14. Once versus thrice daily tobramycin alone and in combination with ceftazidime, ciprofloxacin and imipenem in an in vitro pharmacodynamic model.
Zelenitsky SA; Karlowsky JA; Hoban DJ; Kabani A; Zhanel GG
Chemotherapy; 1998; 44(1):1-6. PubMed ID: 9444401
[TBL] [Abstract][Full Text] [Related]
15. Interactions of antimicrobial combinations in vitro: the relativity of synergism.
Blaser J
Scand J Infect Dis Suppl; 1990; 74():71-9. PubMed ID: 2129067
[TBL] [Abstract][Full Text] [Related]
16. Vanillin selectively modulates the action of antibiotics against resistant bacteria.
Bezerra CF; Camilo CJ; do Nascimento Silva MK; de Freitas TS; Ribeiro-Filho J; Coutinho HDM
Microb Pathog; 2017 Dec; 113():265-268. PubMed ID: 29107747
[TBL] [Abstract][Full Text] [Related]
17. In-vitro studies of antibiotic combinations with special emphasis on the evaluation of newly developed methods.
Zinner SH; Blaser J
J Antimicrob Chemother; 1986 Mar; 17 Suppl A():1-5. PubMed ID: 3086275
[TBL] [Abstract][Full Text] [Related]
18. In-vitro activity of pefloxacin compared to other antibiotics.
Yourassowsky E; Van der Linden MP; Crokaert F; Glupczynski Y
J Antimicrob Chemother; 1986 Apr; 17 Suppl B():19-28. PubMed ID: 3086279
[TBL] [Abstract][Full Text] [Related]
19. [In vitro effect of combinations of netilmicin and amikacin with fosfomycin and pefloxacin on 31 strains of heterogeneous methicillin- resistant Staphylococcus aureus].
David C; Chaste A; Saison C; Combremont AG
Pathol Biol (Paris); 1988 Jun; 36(5 Pt 2):608-12. PubMed ID: 3054735
[TBL] [Abstract][Full Text] [Related]
20. Bactericidal activity and killing rate of serum in volunteers receiving pefloxacin alone or in combination with ceftazidime, piperacillin or mezlocillin against Pseudomonas aeruginosa.
Van der Auwera P; Husson M; Klastersky J
J Antimicrob Chemother; 1988 Jan; 21(1):49-55. PubMed ID: 3128521
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
